瑞加诺生负荷心肌灌注显像对左束支传导阻滞或心室起搏患者的预后价值
回顾性队列研究纳入562例左束支传导阻滞或心室起搏节律患者,接受瑞加诺生负荷SPECT心肌灌注显像。平均随访2.5±1.9年,39例(6.9%)发生主要不良心脏事件(MACE)。异常MPI和心肌缺血可独立且增量预测MACE,在左束支传导阻滞与心室起搏亚组中预测作用相似。
要点
- 瑞加诺生负荷SPECT-MPI在左束支传导阻滞或心室起搏患者中提供独立且增量的预后价值。
- 正常MPI患者年化MACE率为0.9%(左束支传导阻滞0.8%;心室起搏1.0%)。
- 异常MPI和心肌缺血预测MACE在左束支传导阻滞与心室起搏亚组间无显著交互作用。
核心结论
- 在左束支传导阻滞和心室起搏节律患者中,瑞加诺生负荷SPECT-MPI对预测不良心脏事件具有独立且增量的预后价值。
研究设计与样本
- 回顾性队列研究纳入562例患者,平均年龄69±11岁,男性53.3%,左束支传导阻滞占50.7%,心室起搏节律占49.3%。
主要发现
- 321例(57.1%)患者MPI异常,192例(34.2%)存在心肌缺血。
- 平均随访2.5±1.9年期间,39例(6.9%)发生MACE(心源性死亡或心肌梗死)。
- 正常MPI患者年化MACE率为0.9%(左束支传导阻滞0.8%;心室起搏1.0%)。
- MACE率随灌注异常负荷(P < 0.001)和心肌缺血负荷(P = 0.001)增加呈显著阶梯式上升。
- 异常MPI(校正风险比4.26;P = 0.001)和心肌缺血(校正风险比2.70;P = 0.003)独立于并增量于重要临床协变量。
临床怎么用
- 对左束支传导阻滞或心室起搏节律患者,瑞加诺生负荷SPECT-MPI可用于风险分层,异常MPI或心肌缺血提示MACE风险增高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vasodilator stress myocardial perfusion imaging (MPI) is the provocative test of choice in patients with left bundle branch block (LBBB) or ventricular paced (V-paced) rhythm. The prognostic value of regadenoson SPECT myocardial perfusion imaging (MPI) in these patients has not been studied. METHODS AND RESULTS: We conducted a retrospective cohort study of 562 patients [mean age, 69 ± 11 years; men, 53.3%] with LBBB (50.7%) or V-paced rhythm (49.3%) who underwent regadenoson stress SPECT-MPI. There were 321 (57.1%) subjects with abnormal MPI and 192 (34.2%) with myocardial ischemia. During a mean follow-up of 2.5 ± 1.9 years, 39 (6.9%) patients had a major adverse cardiac event (MACE), defined as cardiac death or myocardial infarction. The annualized MACE rate in patients with normal MPI was 0.9% (LBBB, 0.8%; V-paced, 1.0%). There was a significant stepwise increase in MACE rates with increasing burdens of perfusion abnormality (P < 0.001) and myocardial ischemia (P = 0.001). Increased risk with abnormal MPI [adjusted hazard ratio, 4.26; P = 0.001] and myocardial ischemia [adjusted hazard ratio, 2.70; P = 0.003] was independent of and incremental to important clinical covariates. Abnormal MPI and myocardial ischemia predicted MACE similarly in both LBBB and V-paced subgroups (interaction P values > 0.05). CONCLUSION: In patients with LBBB and V-paced rhythm, regadenoson stress SPECT-MPI provides independent and incremental prognostic value in predicting adverse cardiac events.
引用
- Iskander F, Iskander M, Gomez J, et al. Prognostic value of regadenoson stress myocardial perfusion imaging in patients with left bundle branch block or ventricular paced rhythm. J Nucl Cardiol. 2019. PMID: 31144225. doi:10.1007/s12350-019-01762-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。